Peter Alperin

688 total citations
14 papers, 518 citations indexed

About

Peter Alperin is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Alperin has authored 14 papers receiving a total of 518 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Alperin's work include Health Systems, Economic Evaluations, Quality of Life (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Diabetes Treatment and Management (2 papers). Peter Alperin is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Diabetes Treatment and Management (2 papers). Peter Alperin collaborates with scholars based in United States, United Kingdom and Germany. Peter Alperin's co-authors include Nicholas J. Wareham, David Eddy, Knut Borch‐Johnsen, Edward W. Gregg, Jaakko Tuomilehto, Richard Kahn, Rury R. Holman, M. Sue Kirkman, Michael P. Stern and Justin Feigelman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Peter Alperin

13 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Alperin United States	11	224	108	82	76	73	14	518
György Rokszin Hungary	12	167 0.7×	92 0.9×	57 0.7×	85 1.1×	44 0.6×	52	402
Richeek Pradhan Canada	12	159 0.7×	106 1.0×	69 0.8×	63 0.8×	34 0.5×	29	545
Greg Carney Canada	12	97 0.4×	118 1.1×	45 0.5×	75 1.0×	71 1.0×	37	620
Nancy Reynoso‐Noverón Mexico	14	145 0.6×	80 0.7×	59 0.7×	179 2.4×	100 1.4×	67	716
Jetty A. Overbeek Netherlands	14	298 1.3×	138 1.3×	115 1.4×	112 1.5×	24 0.3×	57	716
Rafael Santamaría Spain	15	83 0.4×	131 1.2×	98 1.2×	44 0.6×	39 0.5×	68	772
Valeria Manicardi Italy	16	519 2.3×	155 1.4×	117 1.4×	64 0.8×	67 0.9×	48	868
Panpan Wang China	9	242 1.1×	117 1.1×	142 1.7×	46 0.6×	21 0.3×	19	663
Josephina G. Kuiper Netherlands	13	154 0.7×	63 0.6×	87 1.1×	182 2.4×	40 0.5×	37	640
Young Duk Yun South Korea	10	176 0.8×	50 0.5×	57 0.7×	40 0.5×	56 0.8×	12	469

Countries citing papers authored by Peter Alperin

Since Specialization

Citations

This map shows the geographic impact of Peter Alperin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Alperin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Alperin more than expected).

Fields of papers citing papers by Peter Alperin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Alperin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Alperin. The network helps show where Peter Alperin may publish in the future.

Co-authorship network of co-authors of Peter Alperin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Alperin. A scholar is included among the top collaborators of Peter Alperin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Alperin. Peter Alperin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Alperin, Peter, S. А. Shalnova, S. А. Boytsov, et al.. (2014). Simulating the Impact of Improved Cardiovascular Risk Interventions on Clinical and Economic Outcomes in Russia. PLoS ONE. 9(8). e103280–e103280. 12 indexed citations

Alperin, Peter, J. Racketa, Uchenna H. Iloeje, et al.. (2014). Modeling effects of SGLT‐2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes. Diabetes Obesity and Metabolism. 16(7). 628–635. 82 indexed citations

Alperin, Peter, Bertrand Cariou, David Eddy, et al.. (2013). A Standardized Vascular Disease Health Check in Europe: A Cost-Effectiveness Analysis. PLoS ONE. 8(7). e66454–e66454. 32 indexed citations

Dinh, Tuan, Uri Ladabaum, Peter Alperin, et al.. (2013). Health Benefits and Cost-effectiveness of a Hybrid Screening Strategy for Colorectal Cancer. Clinical Gastroenterology and Hepatology. 11(9). 1158–1166. 44 indexed citations

Alperin, Peter, et al.. (2012). Comparing the effectiveness of rosuvastatin and atorvastatin in preventing cardiovascular outcomes: estimates using the Archimedes model. Journal of Medical Economics. 15(6). 1118–1129. 15 indexed citations

Alperin, Peter, et al.. (2012). Modeling the Impact of Increased Adherence to Asthma Therapy. PLoS ONE. 7(12). e51139–e51139. 19 indexed citations

Dinh, Tuan, Peter Alperin, Louise C. Walter, & Robert A. Smith. (2012). Impact of Comorbidity on Colorectal Cancer Screening Cost-Effectiveness Study in Diabetic Populations. Journal of General Internal Medicine. 27(6). 730–738. 14 indexed citations

Alperin, Peter, et al.. (2011). PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL. Value in Health. 14(3). A36–A36. 1 indexed citations

Green, Linda E., et al.. (2011). Cost‐effectiveness of chemoprevention of breast cancer using tamoxifen in a postmenopausal US population. Cancer. 117(15). 3322–3331. 21 indexed citations

10.

Arondekar, Bhakti, et al.. (2011). Estimating Health and Economic Benefits from Using Prescription Omega-3 Fatty Acids in Patients With Severe Hypertriglyceridemia. The American Journal of Cardiology. 108(5). 691–697. 11 indexed citations

11.

Kahn, Richard, Peter Alperin, David Eddy, et al.. (2010). Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis. The Lancet. 375(9723). 1365–1374. 192 indexed citations

12.

Alperin, Peter, et al.. (2010). Modeling the effects of omalizumab over 5 years among patients with moderate-to-severe persistent allergic asthma. Current Medical Research and Opinion. 26(12). 2779–2793. 6 indexed citations

13.

Dinh, Timothy A., et al.. (2010). Cost-effectiveness of adding information about common risk alleles to current decision models for breast cancer chemoprevention.. Journal of Clinical Oncology. 28(15_suppl). 6042–6042.

14.

MacGregor, James T., Robert Schlegel, Carol M. Wehr, Peter Alperin, & B N Ames. (1990). Cytogenetic damage induced by folate deficiency in mice is enhanced by caffeine.. Proceedings of the National Academy of Sciences. 87(24). 9962–9965. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact